Beware - werkgeversreview Appeals Representative bij Humana

2,0
24 jun 2024
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Pay, time-off, and financial programs/benefits

Minpunten

Management, training, no consistency nor oversight. Jobs may not be secure due to focus being on government contracts like Medicaid and Medicare and the constant profit losses working against the gains. Their profits took a hit 4th quarter of 2023, an approximate $541 million loss (NYSE symbol: HUM). A few years back, they introduced voluntary early retirement to trim costs. With the restructuring of roles in many areas, it seems as if they're flying by the seat of their pants at times. Many of their systems, especially those used for claims, are antiquated - about at least 10 years behind current technology and could really use an overhaul. Don't be fooled by the openings as good number of them are related to turnover. A new CEO, Jim Rechtin, takes over on July 1, 2024 - whether this will be good remains to be seen. I recommend keeping an eye on stuff like going to MSN Money, type in the symbol (HUM) and do your due diligence. You can even see (under the 'Company' tab) when the executives sell (dump?) their company stock - that's never a good sign.

Ontdek andere reviews over Humana

5,0
17 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Making all the right moves to be a leader in 21st century health care.

Minpunten

Legacy technology and corporate structures still create friction, but improving.

3,0
14 mei 2026
Anonieme werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Interesting work, decent benefits, ability to work from home

Minpunten

Cutthroat culture that does not care about employees or their well being, focus on profit at the expense of people, continuous layoffs and outsourcing initiatives

2
Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle